Skip to main content

and
  1. Article

    Open Access

    Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease

    Depressive symptoms are common in patients with Parkinson’s disease and depression is a significant predictor of functional impairment, reduced quality of life and general well-being in Parkinson's disease. De...

    A Schrag, C Carroll, G Duncan, S Molloy, L Grover, R Hunter, R Brown in BMC Neurology (2022)

  2. Article

    Open Access

    The motor prodromes of parkinson’s disease: from bedside observation to large-scale application

    There is sufficient evidence that the pathological process that causes Parkinson’s disease begins years before the clinical diagnosis is made. Over the last 15 years, there has been much interest in the existe...

    C. Simonet, A. Schrag, A. J. Lees, A. J. Noyce in Journal of Neurology (2021)

  3. Article

    Open Access

    Patient experiences of receiving a diagnosis of Parkinson’s disease

    To report patients’ own experiences of receiving a diagnosis of Parkinson’s disease (PD) and to identify factors influencing this experience.

    A. Schrag, S. Modi, S. Hotham, R. Merritt, K. Khan, L. Graham in Journal of Neurology (2018)

  4. No Access

    Article

    MSA-QoL: spezifisches Bewertungsinstrument zur Erfassung der Lebensqualität bei Multisystematrophie

    Die Multisystematrophie (MSA) ist eine rasch fortschreitende neurodegenerative Erkrankung mit früher Pflegeabhängigkeit und einem beträchtlichen Leidensdruck. Daher ist die Erfassung der gesundheitsbezogenen L...

    F. Krismer, S. Duerr, M. Minnerop, T. Klockgether, M. Stamelou in Der Nervenarzt (2013)

  5. No Access

    Reference Work Entry In depth

    Health-Related Quality of Life in Movement Disorders

    This paper reviews the literature on health status and quality of life (QOL) in patients with movement disorders with a focus on the following diseases: Parkinson’s disease

    R. Dodel, A. Schrag in Handbook of Disease Burdens and Quality of Life Measures (2010)

  6. No Access

    Article

    The European Multiple System Atrophy-Study Group (EMSA-SG)

    Introduction. The European Multiple System Atrophy-Study Group (EMSA-SG) is an academic network comprising 23 centers across Europe and Israel that has constituted itself already in January 1999. This internation...

    F. Geser, K. Seppi, M. Stampfer-Kountchev in Journal of Neural Transmission (2005)

  7. No Access

    Article

    Quality of life in patients with orthostatic tremor

    We assessed health-related quality of life (QoL) and depression, using the SF-36 and the Beck Depression Inventory (BDI), in 20 orthostatic tremor (OT) patients. All dimensions of the SF-36 were markedly redu...

    W. Gerschlager, R. Katzenschlager, A. Schrag, A. J. Lees, P. Brown in Journal of Neurology (2003)

  8. No Access

    Article

    Essential tremor: an overdiagnosed condition?

    The diagnosis of essential tremor (ET) and its differentiation from other types of tremor is often difficult. In 1994 Bain et al. defined a classical phenotype by studying 20 patients with pure essential trem...

    A. Schrag, A. Münchau, K.P. Bhatia, N.P. Quinn, C.D. Marsden in Journal of Neurology (2000)